CRL Charles River Laboratories International, Inc.

NYSE
$327.93

Charles River Laboratories International, Inc. (CRL) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus CRL's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
2
4 transactions
Purchases
$0
0 shares
Sales
$19.5M
60,740 shares
Net activity
-$19.5M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $19.5M 4 transactions · 60,740 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $10.1M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 3, 2026 , by LaPlume Joseph W .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
FOSTER JAMES C Director Sell 10b5-1 24,042 $350.00 $8.4M 31,596 −43.2% of holding
Parisotto Shannon M CEVP, Disc & Safety Assessment Sell 10b5-1 2,156 $344.41 $742.5K 4,807 −31% of holding
Parisotto Shannon M CEVP, Disc & Safety Assessment Sell 10b5-1 981 $308.44 $302.6K 4,807 −16.9% of holding
FOSTER JAMES C Director Sell 10b5-1 33,561 $300.00 $10.1M 31,596 −51.5% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.